SCHEMBL8239665

SCHEMBL8239665

NCC(C(=O)Nc1cc(-c2c[nH]c3ncccc23)c(-c2ccoc2)s1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 10/20 0.58
MAP3K5 Q99683 1/20 0.53
AKT3 Q9Y243 2/20 0.38
AKT2 P31751 1/20 0.38
MAP4K4 O95819 2/20 0.38
DYRK1A Q13627 2/20 0.38
MELK Q14680 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
STK17A Q9UEE5 2/20 0.38
CDK8 P49336 2/20 0.38
CDC7 O00311 1/20 0.38
MAPK14 Q16539 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
ROCK2 O75116 4/20 0.38
ROCK1 Q13464 2/20 0.38
CHEK1 O14757 1/20 0.38
RPS6KA5 O75582 1/20 0.38
CHEK2 O96017 1/20 0.38
PRKCG P05129 1/20 0.38
CDK1 P06493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4582334 0.94 AKT1 (0.51) AKT1MAP3K5AKT3AKT2MAP4K4
SCHEMBL4582358 0.87 MAP3K5 (0.49) AKT1MAP3K5AKT3AKT2MAP4K4
SCHEMBL8235518 0.82 AKT1 (0.77) AKT1AKT3AKT2MAP4K4DYRK1A
SCHEMBL4582789 0.79 AKT1 (0.64) AKT1MAP4K4DYRK1AMELKCLK4
SCHEMBL8233616 0.78 AKT1 (0.76) AKT1MAP3K5AKT3MAP4K4DYRK1A
SCHEMBL4582970 0.78 MAP3K5 (0.39) AKT1MAP3K5AKT3MAP4K4DYRK1A
SCHEMBL4583788 0.77 AKT1 (0.46) AKT1MAP3K5AKT3AKT2MAP4K4
SCHEMBL4584368 0.77 AKT1 (0.59) AKT1MAP3K5AKT3AKT2MAPK14
SCHEMBL8240317 0.74 AKT1 (0.45) AKT1MAP3K5MAPK14ROCK2ROCK1
SCHEMBL8240614 0.74 AKT1 (1.00) AKT1AKT3AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007076423-A2 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2007-07-05 WO disclosed